Abstract
Offshore outsourcing has evolved from cost-only strategy to growth strategy in knowledge-intensive industries (KIIs) such as the pharmaceutical industry. This paper explores the case of offshore outsourcing of pharmaceutical manufacturing to India. An extensive literature review shows that firms do engage in offshore outsourcing to India have access to talents, infrastructure as well as markets. Despite the bright future of offshore outsourcing of pharmaceutical industries to India, inadequate protection of intellectual property rights (IPRs), scarcity of highly skilled manpower and institutional shortcomings can pose serious challenges. The study finds that institutional policy framework for promotion of collaborative research and development (R&D) as well as investment in infrastructures and human capital development can keep the momentum in this sector of high-tech industry.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
